McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M et al (2022) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 24(1):4–131. https://doi.org/10.1002/ejhf.2333

Article  PubMed  Google Scholar 

Rosano GMC, Maura B, Metra M, Böhm M, Bauersachs J, Ben Gal T et al (2021) Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 23(6):872–881. https://doi.org/10.1002/ejhf.2206

Article  PubMed  Google Scholar 

Bozkurt B (2019) Reasons for lack of improvement in treatment with evidence-based therapies in heart failure. J Am Coll Cardiol 73(19):2384–2387. https://doi.org/10.1016/j.jacc.2019.03.464

Article  PubMed  Google Scholar 

Komajda M, Schöpe J, Wagenpfeil S, Tavazzi L, Böhm M, Ponikowski P et al (2019) Physicians’ guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry. Eur J Heart Fail 21(7):921–929. https://doi.org/10.1002/ejhf.1459

Article  PubMed  Google Scholar 

Savarese G, Kishi T, Vardeny O, Adamsson Eyrd S, Bodegård J, Lund LH et al (2023) Heart failure drug treatment—Inertia, titration, and discontinuation. JACC Heart Fail 11(1):1–14. https://doi.org/10.1016/j.jchf.2022.08.009

Article  CAS  PubMed  Google Scholar 

Taylor RS, Dalal HM, Zwisler AD (2023) Cardiac rehabilitation for heart failure: ‘Cinderella’ or evidence-based pillar of care? Eur Heart J 44(17):1511–1518. https://doi.org/10.1093/eurheartj/ehad118

Article  PubMed  PubMed Central  Google Scholar 

Ambrosetti M, Abreu A, Corrà A, Hansen D, Frederix I, Iliou MC et al (2021) Secondary prevention through comprehensive cardiovascular rehabilitation: from knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol 28(5):460–495. https://doi.org/10.1177/2047487320913379

Article  PubMed  Google Scholar 

Molloy C, Long L, Mordi IR, Bridges C, Sagar VA, Davies EJ et al (2024) Exercise-based cardiac rehabilitation for adults with heart failure. Cochrane Database Syst Rev 3(3):CD003331. https://doi.org/10.1002/14651858.CD003331.pub6

Article  PubMed  Google Scholar 

Golwala H, Pandey A, Ju C, Butler J, Yancy C, Bhatt DL et al (2015) Temporal trends and factors associated with cardiac rehabilitation referral among patients hospitalized with heart failure. J Am Coll Cardiol 66(8):917–926. https://doi.org/10.1016/j.jacc.2015.06.1089

Article  PubMed  Google Scholar 

Ades PA, Keteyian SJ, Wright JS, Hamm LF, Lui K, Newlin K et al (2017) Increasing cardiac rehabilitation participation from 20% to 70%: a road map from the million hearts cardiac rehabilitation collaborative. Mayo Clin Proc 92(2):234–242. https://doi.org/10.1016/j.mayocp.2016.10.014

Article  PubMed  Google Scholar 

Lund LH, Crespo-Leiro MG, Laroche C, Garcia-Pinilla JM, Bennis A, Vataman EB et al (2023) Rationale and design of the ESC heart failure III registry—implementation and discovery. Eur J Heart Fail 25(12):2316–2330. https://doi.org/10.1002/ejhf.3087

Article  PubMed  Google Scholar 

McMurray JJV, Packer M, Desai A, Gong J, Lefkowitz MP et al (2014) Angiotensin–neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371(11):993–1004. https://doi.org/10.1056/NEJMoa1409077

Article  CAS  PubMed  Google Scholar 

Carnicelli AP, Lippman SJ, Greene SJ, Mentz RJ, Greiner MA, Hardy NC et al (2021) Sacubitril/valsartan initiation and postdischarge adherence among patients hospitalized for heart failure. J Card Fail 27(8):826–836. https://doi.org/10.1016/j.cardfail.2021.03.012

Article  PubMed  Google Scholar 

Sauer AJ, Cole R, Jensen B, Pal J, Sharma N, Yehya A et al (2019) Practical guidance on the use of sacubitril/valsartan for heart failure. Heart Fail Rev 24(2):167–176. https://doi.org/10.1007/s10741-018-9757-1

Article  CAS  PubMed  Google Scholar 

Paolillo S, Mapelli M, Bonomi A, Corrà U, Piepoli M, Veglia F et al (2017) Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database. Eur J Heart Fail 19(7):904–914. https://doi.org/10.1002/ejhf.775

Article  CAS  PubMed  Google Scholar 

Prins KW, Neill JM, Tyler JO, Eckman PM, Duval S (2015) Effects of beta-blocker withdrawal in acute decompensated heart failure. JACC Heart Fail 3(8):647–653. https://doi.org/10.1016/j.jchf.2015.03.008

Article  PubMed  PubMed Central  Google Scholar 

Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341(10):709–717. https://doi.org/10.1056/NEJM199909023411001

Article  CAS  PubMed  Google Scholar 

Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B et al (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348(14):1309–1321. https://doi.org/10.1056/NEJMoa030207

Article  CAS  PubMed  Google Scholar 

McMurray JJV, Solomon SD, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA et al (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381(21):1995–2008. https://doi.org/10.1056/NEJMoa1911303

Article  CAS  PubMed  Google Scholar 

Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P et al (2020) Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med 383(15):1413–1424. https://doi.org/10.1056/NEJMoa2022190

Article  CAS  PubMed  Google Scholar 

Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Böhm M et al (2021) Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med 385(16):1451–1461. https://doi.org/10.1056/NEJMoa2107038

Article  CAS  PubMed  Google Scholar 

Solomon SD, McMurray JJV, Claggett B, de Boer RA, DeMets D, Hernandez AF et al (2022) Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med 387(12):1089–1098. https://doi.org/10.1056/NEJMoa2206286

Article  PubMed  Google Scholar 

Heerspink HJL, Stefánsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF et al (2020) Dapagliflozin in patients with chronic kidney disease. N Engl J Med 383(15):1436–1446. https://doi.org/10.1056/NEJMoa2024816

Article  CAS  PubMed  Google Scholar 

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604. https://doi.org/10.7326/0003-4819-150-9-200905050-00006

Article  PubMed  PubMed Central  Google Scholar 

Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S et al (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373(22):2117–2128. https://doi.org/10.1056/NEJMoa1504720

Article  CAS  PubMed  Google Scholar 

Voors AA, Angermann CE, Teerlink JR, Collins SP, Kosiborod M, Biegus J et al (2022) The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial. Nat Med 28(3):568–574. https://doi.org/10.1038/s41591-021-01659-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Epelde F (2024) Optimizing cardiac rehabilitation in heart failure: Comprehensive insights, barriers, and future strategies. Medicina (B Aires) 60(10):1583. https://doi.org/10.3390/medicina60101583

Article  Google Scholar 

Piepoli MF, Abreu A, Albus C, Ambrosetti M, Brotons C, Catapano AL et al (2020) Update on cardiovascular prevention in clinical practice: a position paper of the European Association of Preventive Cardiology of the European Society of Cardiology. Eur J Prev Cardiol 27(2):181–205. https://doi.org/10.1177/2047487319893035

Article  PubMed  Google Scholar 

Tegegne TK, Rawstorn JC,